China’s economy grew slightly slower than expected in the second quarter, weighed down by higher raw materials costs and new COVID-19 outbreaks. Expectations build that policymakers may have to do more to support the recovery.
The leading 14 Big Pharma firms paid out more to enrich their investors than they spent on research and development from 2016 to 2020, according to a report by the U.S. House Oversight Committee. The report also divulged big payments to top executives.
A rebound in growth and technology stocks has investors gauging whether a months-long rally in the shares of banks, energy companies and other economically sensitive names is running on empty or simply refueling.
Shares of electric carmaker Tesla–last year’s best-performing S&P 500 stock—plunged to their lowest level in three months Monday as the broader market rallied—yet another sign the recently booming market for tech stocks could be over, once postpandemic spending drives growth into other industries.
